Lilly has recently announced their goal to expand global access to healthcare for 30 million people in resource-limited locations by 2030. The scheme, known as Lilly 30×30, is a new five-year, $90 million investment in the Lilly Global Health Partnership, to improve access to treatment for diabetes, cancer and tuberculosis.
One half of the $90 million commitment will come from the Eli Lilly and Company Foundation; the other portion will come from company funds. Continue reading
At the Clinical Professionals Group, we strive to not only be innovative, but also proactive and our Training Academy is just one of the many services we provide as a service to the Life Science Industry.
The Academy was first initiated towards the end of 2014, as a result of witnessing the lack of newly trained candidates to fill the large quantity of entry level roles available within the life science industry, and in particular the clinical research sector. Continue reading
Clinical Professionals are delighted to announce the launch of the new Scientific Professionals’ website!
Scientific Professionals, part of the Clinical Professionals Group was formed in response to focus on the needs of clients by finding key hires for their business. We pride ourselves on generating and maintaining successful, honest and professional partnerships with all of our contacts. Continue reading
Bristol-Myers Squibb Company and Nektar Therapeutics have announced a new clinical collaboration to evaluate combining Bristol-Myers Squibb’s Opdivo with Nektar’s investigational medicine, NKTR-214, as a potential treatment regimen in five different tumour types and seven potential indications. Opdivo is a PD-1 immune checkpoint inhibitor designed to overcome immune suppression. Whilst NKTR-214 is an investigational immuno-stimulatory therapy designed to expand specific cancer-fighting T cells and natural killer (NK) cells directly in the tumour micro-environment and increase expression of PD-1 on these immune cells. Continue reading
Bayer and Evotec have recently signed a five-year, multi-target research pact with the aim to develop multiple clinical candidates for the treatment of chronic kidney diseases.
Both parties will contribute novel drug targets and a comprehensive set of high-quality technology platforms to jointly develop new innovative treatment options for patients, and will share responsibilities during preclinical development. Continue reading
A study funded by the NIHR, NIH, Wellcome Trust and the Medical Research Council have discovered 31 new gene regions that are linked with blood pressure. Hailed as one of the largest studies to date, the study involves over 347,000 people led by Queen Mary’s university of London and the University of Cambridge.
Our Brexit industry analytics report was created as a product of the Clinical Professionals Group collaboration with VacancySoft. The ongoing partnership aims to produce a regular report that provides an extensive analysis of the vacancies available in a variety of different sectors, countries and areas of the life sciences industry. Continue reading
We are delighted to announce that The Clinical Professionals group are shortlisted for the APSCo “Recruitment Company with the Most Sustainable Growth” award.
The award recognises companies that have shown consistent growth over the past 5 years whilst demonstrating the professional values and exceptional performance associated with APSCo membership. We were required to demonstrate how this growth was achieved, what set us apart from others, how we develop and train staff whilst also ensuring our company is legally and ethically compliant. Continue reading
Throughout August, The Clinical Professionals Group celebrated the Olympics with our very own Rio themed activities to help raise money for our corporate charity, the Arrows Group Foundation.
Whilst not only taking part in a results driven competition each week, Clinical Professionals employees also celebrated every Friday with fancy dress, bake sales and fun activities. Continue reading
As many students begin to embark upon their journey through university next month, many who have already graduated and obtained their degree can be at a loss for what to do next, but we have the solution…
Quite often graduates find themselves looking to begin their career within their particular specialisation, but are often turned down due to lack of experience or gaps within their training and the Life Science industry is no different. Continue reading